Impact of pre-existing interstitial lung abnormalities on pneumonitis risk and survival in chemo-naive patients with non-small-cell lung cancer receiving pembrolizumab plus chemotherapy.

Saved in:
Bibliographic Details
Title: Impact of pre-existing interstitial lung abnormalities on pneumonitis risk and survival in chemo-naive patients with non-small-cell lung cancer receiving pembrolizumab plus chemotherapy.
Authors: Machiyama H; Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, The University of Osaka, 2-2 Yamadaoka, Suita City, Osaka, 565-0871, Japan; Department of Immunogenomic Medicine, Research Institute, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan., Matsumoto K; Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, The University of Osaka, 2-2 Yamadaoka, Suita City, Osaka, 565-0871, Japan., Shiroyama T; Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, The University of Osaka, 2-2 Yamadaoka, Suita City, Osaka, 565-0871, Japan. Electronic address: takayuki.s12@hotmail.co.jp., Miyazaki A; Department of Respiratory Medicine, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka, 540-8567, Japan., Komuta K; Department of Respiratory Medicine, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka, 540-8567, Japan., Tamiya M; Department of Respiratory Medicine, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka, 540-8567, Japan., Tsukaguchi A; Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, The University of Osaka, 2-2 Yamadaoka, Suita City, Osaka, 565-0871, Japan; Department of Internal Medicine, NHO Kinki Chuo Chest Medical Center, 1180, Nagasone-cho Kita-ku, Sakai, Osaka, 591-8555, Japan., Tamiya A; Department of Internal Medicine, NHO Kinki Chuo Chest Medical Center, 1180, Nagasone-cho Kita-ku, Sakai, Osaka, 591-8555, Japan., Kinehara Y; Department of Respiratory Medicine and Clinical Immunology, Nippon Life Hospital, 2-1-54 Enokojima, Nishi-ku, Osaka, 550-0006, Japan., Moritomo K; Department of Respiratory Medicine, Osaka Keisatsu Hospital, 10-31 Kitayama-cho, Tennoji-ku, Osaka, 543-8555, Japan., Shoshihara N; Department of Respiratory Medicine, Osaka Keisatsu Hospital, 10-31 Kitayama-cho, Tennoji-ku, Osaka, 543-8555, Japan., Kuge T; Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, The University of Osaka, 2-2 Yamadaoka, Suita City, Osaka, 565-0871, Japan; Department of Thoracic Oncology, NHO Osaka Toneyama Medical Center, 5-1-1 Toneyama, Toyonaka City, Osaka, 560-8552, Japan., Mihashi Y; Department of Thoracic Oncology, NHO Osaka Toneyama Medical Center, 5-1-1 Toneyama, Toyonaka City, Osaka, 560-8552, Japan., Mori M; Department of Thoracic Oncology, NHO Osaka Toneyama Medical Center, 5-1-1 Toneyama, Toyonaka City, Osaka, 560-8552, Japan., Yamauchi K; Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, The University of Osaka, 2-2 Yamadaoka, Suita City, Osaka, 565-0871, Japan; Department of Thoracic Oncology, Osaka Habikino Medical Center, 3-7-1 Habikino, Habikino-shi, Osaka, 583-8588, Japan., Suzuki H; Department of Thoracic Oncology, Osaka Habikino Medical Center, 3-7-1 Habikino, Habikino-shi, Osaka, 583-8588, Japan., Kato S; Department of Respiratory Medicine, Ikeda City Hospital, 3-1-18 Jonan, Ikeda City, Osaka, 563-8510, Japan., Nishikawa Y; Department of Respiratory Medicine, Toyonaka Municipal Hospital, 4-14-1 Shibahara-cho, Toyonaka-shi, Osaka, 560-8565, Japan., Niki T; Department of Respiratory Medicine, Nishinomiya Municipal Central Hospital, 8-24 Hayashida-cho, Nishinomiya City, Hyogo, 663-8014, Japan., Azuma K; Department of Respiratory Medicine, National Hospital Organization Osaka National Hospital, 2-1-14 Hoenzaka, Chuo-ku, Osaka, 540-0006, Japan., Osa A; Department of Respiratory Medicine, Kinki Central Hospital, 3-1 Kurumazuka, Itami City, Hyogo, 664-8533, Japan., Takeda Y; Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, The University of Osaka, 2-2 Yamadaoka, Suita City, Osaka, 565-0871, Japan., Kumanogoh A; Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, The University of Osaka, 2-2 Yamadaoka, Suita City, Osaka, 565-0871, Japan; Department of Immunopathology, World Premier International (WPI), Immunology Frontier Research Center (iFReC), The University of Osaka, 3-1 Yamadaoka, Suita City, Osaka, 565-0871, Japan; Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives (OTRI), The University of Osaka, 2-2 Yamadaoka, Suita City, Osaka, 565-0871, Japan; Center for Infectious Diseases for Education and Research (CiDER), The University of Osaka, 1-10 Yamadaoka, Suita City, Osaka, 565-0871, Japan; Japan Agency for Medical Research and Development - Core Research for Evolutional Science and Technology (AMED-CREST), The University of Osaka, 2-2 Yamadaoka, Suita City, Osaka, 565-0871, Japan; Center for Advanced Modalities and DDS (CAMaD), The University of Osaka, 1-10 Yamadaoka, Suita City, Osaka, 565-0871, Japan.
Source: Respiratory medicine [Respir Med] 2026 Jun; Vol. 257, pp. 108852. Date of Electronic Publication: 2026 Apr 21.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 8908438 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-3064 (Electronic) Linking ISSN: 09546111 NLM ISO Abbreviation: Respir Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1532-3064
DOI:10.1016/j.rmed.2026.108852